FILE PHOTO: A logo of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer/File Photo
BENGALURU (Reuters) -India has given emergency use authorization for a COVID-19 antibody drug cocktail developed by Roche and Regeneron, expanding its arsenal of drugs to battle a massive second wave of infections.
The decision was taken based on data filed with the U.S. regulators and the scientific opinion of a European regulatory panel, Roche's India distribution partner for the drug, Cipla, said on Wednesday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
